Boehringer Ingelheim Vetmedica, Inc., Press Releases

See the latest BIVI press releases. To quickly find all press releases on a specific topic, please use the search.

Press Release Archive

Pages

12.12.2018

Boehringer Ingelheim Announces Winners of 2018 Champions of the Cause Awards

10.02.2018

Introducing SEMINTRA® (telmisartan oral solution) —The First FDA-Approved Liquid Solution For Feline Hypertension 

09.12.2018

Boehringer Ingelheim to Donate 75,000 Doses of Rabies Vaccine to the Global Alliance for Rabies Control Through Shots for Good Initiative

09.05.2018

Researchers focused on infectious respiratory disease in pigs may apply for Boehringer Ingelheim research awards

08.27.2018

FDA approves NexGard® (afoxolaner) for the prevention of infections that cause Lyme disease in dogs

08.20.2018

Boehringer Ingelheim Announces the Launch of Centragard™ (eprinomectin and praziquantel transdermal solution), Innovative Internal Parasite Protection For Cats

08.06.2018

Dairy Calf Health Practices Impact Production Capabilities 

08.06.2018

Annual National Veterinary Scholars Symposium Showcases Young Talent and Value of Hands-on Research Opportunities for Students

06.12.2018

Newport Laboratories is now part of Boehringer Ingelheim

03.06.2018

Announcing 2018 Recipients of the Awards for Advancing Research in Respiratory Disease

03.05.2018

Introducing Ingelvac Provenza™—the birth of a new generation in swine protection.

02.06.2018

Experts Discuss Lone Star Tick Population, Associated Disease

02.05.2018

MERIAL, Now Part of BOEHRINGER INGELHEIM, Grows Canine Vaccine Portfolio With Introduction of RECOMBITEK® Oral Bordetella

01.24.2018

Boehringer Ingelheim Launches SwineResource.com

12.04.2017

Boehringer Ingelheim Invests $80 Million to Expand Animal Vaccine Manufacturing Capacity in the U.S.

Pages